Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Leafbuyer Technologies Inc
LBUY
Healthcare
Specialty Retail
Cannabis
Leafbuyer Technologies, Inc. provides a comprehensive marketing technology platform. The Company's clients, medical and recreational dispensaries, in legalized cannabis states, along with cannabis product companies subscribe to its technology platform to assist in new customer acquisition. It provides retention tools to those companies that include texting/loyalty and ordering ahead technology....
Its Leafbuyer Technology Platform reaches many cannabis consumers every month through its Web-based platform, loyalty platform and smart application technology. The Company's Website's sophisticated vendor dashboard allows its clients to update their menus, deals and create real-time messages to communicate with consumers 24/7. Through its total network program, text messages that are sent are converted into add units that are posted to Leafbuyer.com in real-time. This is part of its Live Deals section and is up to the minute content that is 100% searchable the minute it goes live.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:LBUY)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
fsabbagh
X
View Profile
View Bullboard History
Post by
fsabbagh
on Jul 31, 2019 11:04am
Killed
What happened? Stock down over 50% with extremely high volume.
(1)
•••
gchristopher2
X
View Profile
View Bullboard History
Comment by
gchristopher2
on Jan 31, 2019 9:24am
RE:Django have good aim
If you bought on March 7, 2018 you haven't made a profit.
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(0)
•••
Cannabeds
X
View Profile
View Bullboard History
Post by
Cannabeds
on Dec 13, 2018 10:06am
Next stop... The Oval Office!
Congress just quietly passed a law that could spark a boom for the $1 billion marijuana-linked CBD industry https://www.ftmig.com/cannabis/congress-just-quietly-passed-a-law-that-could-spark-a
...more
(0)
•••
Money pit
X
View Profile
View Bullboard History
Post by
Money pit
on Sep 28, 2018 9:29am
Any idea where it’s going to be $$$ in a week?
I just started following this sp.. if you have any idea where the price should be in the future I will listen
(7)
•••
Django666
X
View Profile
View Bullboard History
Post by
Django666
on Mar 07, 2018 9:30am
Django have good aim
Django buy. Django make profit.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments